A naukri.com initiative
Bioengineer
7d
411
Image Credit: Bioengineer
Dnajc12 Knockout Mice Show Biogenic Amine Deficiency
- Researchers find a crucial link between central biogenic amine deficiency and abnormal behaviors in Dnajc12 gene knockout mice, shedding light on neurodegenerative conditions like Parkinson’s disease.
- Biogenic amines such as dopamine and serotonin play essential roles in brain functions, and their imbalance can lead to motor deficits and cognitive issues seen in Parkinsonian syndromes.
- The absence of the Dnajc12 gene in mice results in reduced concentrations of central biogenic amines and significant deficits in exploratory behavior.
- Advanced neurochemical assays reveal reduced dopamine and serotonin levels in brain regions crucial for Parkinson's pathology in Dnajc12 knock-out mice.
- Behavioral tests show that Dnajc12-deficient mice exhibit decreased locomotion, reduced curiosity in new environments, and altered anxiety responses.
- The study suggests that targeting Dnajc12 or its downstream pathways could offer new therapeutic targets for Parkinson’s disease and other neurological disorders.
- The research highlights Dnajc12's role in maintaining enzymes responsible for biogenic amine synthesis, leading to neurotransmitter depletion when the gene is lost.
- The findings implicate Dnajc12 in modulating activity and environmental engagement, reflecting features observed in Parkinson's patients.
- Neuroanatomical changes in Dnajc12-deficient mice suggest a role in neurodegenerative processes beyond neurotransmitter deficits.
- The study underscores the potential for gene-targeted therapies to address biogenic amine dysregulation and behavioral alterations, opening avenues for precision medicine in neurodegeneration.
Read Full Article
24 Likes
For uninterrupted reading, download the app